TP53基因突变及其等位状态对伴孤立5q缺失的骨髓增生异常综合征的影响
本研究对682例伴孤立5q缺失的骨髓增生异常综合征(MDS-del(5q))患者进行TP53突变及等位失衡综合分析,发现24%的TP53突变患者存在多重打击改变,其余为单等位突变。TP53多重打击改变预示白血病转化风险增加;单等位突变的影响取决于变异等位基因频率(VAF),VAF<20%者行为类似TP53野生型,VAF≥20%者结局等同于多重打击患者。
要点
- 682例MDS-del(5q)患者中,TP53突变者24%为多重打击改变,其余为单等位突变。
- TP53多重打击改变预示白血病转化风险增加。
- 单等位TP53突变VAF<20%者行为类似野生型,VAF≥20%者结局等同于多重打击患者。
核心结论
- TP53等位状态和VAF应纳入MDS-del(5q)患者的风险分层和治疗决策。
研究设计与样本
- 对682例诊断为MDS-del(5q)的患者进行TP53异常(包括TP53突变和等位失衡)的综合分析。
主要发现
- 24%的TP53突变患者存在多重打击改变,其余患者为单等位突变。
- TP53多重打击改变预示白血病转化风险增加。
- TP53单等位突变且VAF<20%的患者行为类似TP53野生型。
- TP53单等位突变且VAF≥20%的患者结局等同于TP53多重打击患者。
临床怎么用
- 作者认为,在MDS-del(5q)患者的风险分层和治疗决策过程中应考虑TP53等位状态和VAF。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mutations in the TP53 gene, particularly multihit alterations, have been associated with unfavorable clinical features and prognosis in patients diagnosed with myelodysplastic syndrome (MDS). Despite this, the role of TP53 gene aberrations in MDS with isolated deletion of chromosome 5 [MDS-del(5q)] remains unclear. This study aimed to assess the impact of TP53 gene mutations and their allelic state in patients with MDS-del(5q). To that end, a comprehensive analysis of TP53 abnormalities, examining both TP53 mutations and allelic imbalances, in 682 patients diagnosed with MDS-del(5q) was conducted. Twenty-four percent of TP53-mutated patients exhibited multihit alterations, whereas the remaining patients displayed monoallelic mutations. TP53-multihit alterations were predictive of an increased risk of leukemic transformation. The impact of monoallelic alterations was dependent on the variant allele frequency (VAF); patients with TP53-monoallelic mutations and VAF <20% exhibited behavior similar to TP53 wild type, and those with TP53-monoallelic mutations and VAF ≥20% presented outcomes equivalent to TP53-multihit patients. This study underscores the importance of considering TP53 allelic state and VAF in the risk stratification and treatment decision-making process for patients with MDS-del(5q).
引用
- Montoro MJ, Palomo L, Haferlach C, et al. Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion. Blood. 2024. PMID: 39074355. doi:10.1182/blood.2024023840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。